Joint Corp. reports Q2 EPS 1c, consensus (2c)

Reports Q1 revenue $13.3M, consensus $13.32M. Reported comp sales of 1.4%. The company said, “At the beginning of 2025, we laid out our multi-year strategy to strengthen our core, reignite growth and improve both clinic and company level profitability, and we’re making progress across these initiatives. We are increasing momentum in becoming a pure play franchisor with 92% franchised clinics in our portfolio at quarter end. By allocating funds to both RD buybacks and our recently established share repurchase program, we are leveraging capital to increase shareholder value. While the macro environment remains dynamic, we are focusing on actions within our control: Fueling our growth flywheel and reducing costs.”